Guest Editorial How insights we gained at AACR will help modernize cancer care in Ukraine May 19, 2023Vol.49 No.20By Serhii Kozhukhov, Olena Yefimenko, Stepan Krulko, Liudmyla Ostrovska, Emily Hubbard and Rostyslav Semikov
Guest Editorial USPSTF breast cancer screening guidelines are clear, concise; now let’s address gaps in quality May 12, 2023Vol.49 No.19By Otis W. Brawley
FreeGuest Editorial A proposal for the Cancer Moonshot: Set up a strategic reserve for lifesaving generic cancer drugs April 28, 2023Vol.49 No.17By Satyajit Kosuri and Mark J. Ratain
Guest Editorial CPRIT leaders: Texas ruling that curbs USPSTF authority threatens progress against cancer April 21, 2023Vol.49 No.16By Michelle M. Le Beau, Ramona Magid and Patty Moore
Guest Editorial Mifepristone and the Administrative Procedure Act: Perspective of a former FDA commissioner and NCI director April 14, 2023Vol.49 No.15By Norman E. "Ned" Sharpless
Guest Editorial Leading a matrix cancer center: Extensive responsibility, modest influence, little authority April 07, 2023Vol.49 No.14By George J. Weiner
FreeGuest Editorial Ukraine’s patients had to choose: What will kill you sooner? Cancer or artillery? February 24, 2023Vol.49 No.08By Anna Uzlova and Inessa Matiushenko
FreeGuest Editorial Ukraine’s cancer care system was in the midst of an overhaul—and then Russia invaded February 24, 2023Vol.49 No.08By Viacheslav Kopetskyi
Guest Editorial The anatomy of my decision to take a PAUSE and explore life outside the cancer center director’s office February 24, 2023Vol.49 No.08By George J. Weiner
Guest Editorial ODAC clears a path for dostarlimab, a drug that may “beat the reaper” in locally advanced rectal cancer February 10, 2023Vol.49 No.06By Richard M. Goldberg
